185 related articles for article (PubMed ID: 26723555)
21. [Impact of PET/CT on precise radiotherapy planning for non-small cell lung cancer].
Gong HY; Yu JM; Fu Z; Li BS; Li JB; Liu TH
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):54-7. PubMed ID: 16737623
[TBL] [Abstract][Full Text] [Related]
22. Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer.
Spratt DE; Diaz R; McElmurray J; Csiki I; Duggan D; Lu B; Delbeke D
Clin Nucl Med; 2010 Apr; 35(4):237-43. PubMed ID: 20305410
[TBL] [Abstract][Full Text] [Related]
23. [The use of PET/CT in radiotherapy of patients with non-small cell lung cancer].
Lõcsei Z; Hideghéty K; Farkas R; Bellyei S; Sárosi V; Sebestyén K; Sebestyén Z; Kovács P; Mangel L
Magy Onkol; 2011 Nov; 55(4):274-80. PubMed ID: 22128310
[TBL] [Abstract][Full Text] [Related]
24. Clinical implications of defining the gross tumor volume with combination of CT and 18FDG-positron emission tomography in non-small-cell lung cancer.
Grills IS; Yan D; Black QC; Wong CY; Martinez AA; Kestin LL
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):709-19. PubMed ID: 17197120
[TBL] [Abstract][Full Text] [Related]
25. Potential of adaptive radiotherapy to escalate the radiation dose in combined radiochemotherapy for locally advanced non-small cell lung cancer.
Guckenberger M; Wilbert J; Richter A; Baier K; Flentje M
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):901-8. PubMed ID: 20708850
[TBL] [Abstract][Full Text] [Related]
26. Dose painting by contours versus dose painting by numbers for stage II/III lung cancer: practical implications of using a broad or sharp brush.
Meijer G; Steenhuijsen J; Bal M; De Jaeger K; Schuring D; Theuws J
Radiother Oncol; 2011 Sep; 100(3):396-401. PubMed ID: 21955663
[TBL] [Abstract][Full Text] [Related]
27. The use of fused PET/CT images for patient selection and radical radiotherapy target volume definition in patients with non-small cell lung cancer: results of a prospective study with mature survival data.
Mac Manus MP; Everitt S; Bayne M; Ball D; Plumridge N; Binns D; Herschtal A; Cruickshank D; Bressel M; Hicks RJ
Radiother Oncol; 2013 Mar; 106(3):292-8. PubMed ID: 23541364
[TBL] [Abstract][Full Text] [Related]
28. A phase II comparative study of gross tumor volume definition with or without PET/CT fusion in dosimetric planning for non-small-cell lung cancer (NSCLC): primary analysis of Radiation Therapy Oncology Group (RTOG) 0515.
Bradley J; Bae K; Choi N; Forster K; Siegel BA; Brunetti J; Purdy J; Faria S; Vu T; Thorstad W; Choy H
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):435-41.e1. PubMed ID: 21075551
[TBL] [Abstract][Full Text] [Related]
29. Use of PET/CT for staging and radiation therapy planning in patients with non-small cell lung cancer.
Mac Manus MP
Q J Nucl Med Mol Imaging; 2010 Oct; 54(5):510-20. PubMed ID: 20927018
[TBL] [Abstract][Full Text] [Related]
30. Hypoxia-guided adaptive radiation dose escalation in head and neck carcinoma: a planning study.
Servagi-Vernat S; Differding S; Sterpin E; Hanin FX; Labar D; Bol A; Lee JA; Grégoire V
Acta Oncol; 2015 Jul; 54(7):1008-16. PubMed ID: 25562382
[TBL] [Abstract][Full Text] [Related]
31. Functional lung volume mapping with perfusion Single-Photon Emission Computed Tomography scan for radiotherapy planning in patients with locally advanced nonsmall cell lung cancer.
Follacchio GA; D'Urso P; Cassese R; Ferrara C; Bulzonetti N; Monteleone F; Musio D; Liberatore M; Tombolini V
Nucl Med Commun; 2020 Oct; 41(10):1026-1033. PubMed ID: 32732597
[TBL] [Abstract][Full Text] [Related]
32. PET-based dose painting in non-small cell lung cancer: Comparing uniform dose escalation with boosting hypoxic and metabolically active sub-volumes.
Even AJ; van der Stoep J; Zegers CM; Reymen B; Troost EG; Lambin P; van Elmpt W
Radiother Oncol; 2015 Aug; 116(2):281-6. PubMed ID: 26238010
[TBL] [Abstract][Full Text] [Related]
33. (18)F-FDG PET-CT simulation for non-small-cell lung cancer: effect in patients already staged by PET-CT.
Hanna GG; McAleese J; Carson KJ; Stewart DP; Cosgrove VP; Eakin RL; Zatari A; Lynch T; Jarritt PH; Young VA; O'Sullivan JM; Hounsell AR
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):24-30. PubMed ID: 19665324
[TBL] [Abstract][Full Text] [Related]
34. Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation: a planning study.
De Ruysscher D; Wanders S; Minken A; Lumens A; Schiffelers J; Stultiens C; Halders S; Boersma L; Baardwijk Av; Verschueren T; Hochstenbag M; Snoep G; Wouters B; Nijsten S; Bentzen SM; Kroonenburgh Mv; Ollers M; Lambin P
Radiother Oncol; 2005 Oct; 77(1):5-10. PubMed ID: 16019093
[TBL] [Abstract][Full Text] [Related]
35. Ventilation/Perfusion Positron Emission Tomography--Based Assessment of Radiation Injury to Lung.
Siva S; Hardcastle N; Kron T; Bressel M; Callahan J; MacManus MP; Shaw M; Plumridge N; Hicks RJ; Steinfort D; Ball DL; Hofman MS
Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):408-17. PubMed ID: 26275510
[TBL] [Abstract][Full Text] [Related]
36. A Prospective Study Comparing Dosimetry between Computed Tomography (CT) based Radiation Planning and Positron Emission Computed Tomography (PET-CT) based Radiation Planning in Treatment of Non-Metastatic Non Small Cell Lung Carcinoma.
Mandal B; Basu A; Manna A; Mondal J; Ghosh D; Chakraborty I; Biswas J; Chakraborty A
Asian Pac J Cancer Prev; 2023 Jul; 24(7):2543-2550. PubMed ID: 37505789
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of adaptive treatment planning for patients with non-small cell lung cancer.
Zhong H; Siddiqui SM; Movsas B; Chetty IJ
Phys Med Biol; 2017 Jun; 62(11):4346-4360. PubMed ID: 28072395
[TBL] [Abstract][Full Text] [Related]
38. Serial assessment of FDG-PET FDG uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC).
Edet-Sanson A; Dubray B; Doyeux K; Back A; Hapdey S; Modzelewski R; Bohn P; Gardin I; Vera P
Radiother Oncol; 2012 Feb; 102(2):251-7. PubMed ID: 21885145
[TBL] [Abstract][Full Text] [Related]
39. A potential to reduce pulmonary toxicity: the use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-small cell lung cancer.
Lavrenkov K; Christian JA; Partridge M; Niotsikou E; Cook G; Parker M; Bedford JL; Brada M
Radiother Oncol; 2007 May; 83(2):156-62. PubMed ID: 17493699
[TBL] [Abstract][Full Text] [Related]
40. Impact of tumour motion compensation and delineation methods on FDG PET-based dose painting plan quality for NSCLC radiation therapy.
Thomas HM; Kinahan PE; Samuel JJE; Bowen SR
J Med Imaging Radiat Oncol; 2018 Feb; 62(1):81-90. PubMed ID: 29193781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]